ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 393

$669K Total Retail Price of All Prescriptions

Rank: 31 out of 393

781 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 781 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 781 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,039 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 548 452 1 1
LISINOPRIL 545 438 2 2
HYDROCODONE-ACETAMINOPHEN 483 336 S3 3 5
LEVOTHYROXINE SODIUM 446 334 4 3
AMLODIPINE BESYLATE 387 307 5 4
OMEPRAZOLE 352 245 6 6
METFORMIN HCL 276 240 7 7
WARFARIN SODIUM 266 188 8 17
FUROSEMIDE 252 195 9 8
ZOLPIDEM TARTRATE 230 137 10 11
GABAPENTIN 220 134 11 15
ATENOLOL 214 182 12 13
LOSARTAN POTASSIUM 190 170 13 12
METOPROLOL TARTRATE 189 147 14 9
HYDROCHLOROTHIAZIDE 173 125 15 10
LOVASTATIN 162 138 16 14
CARISOPRODOL 149 40 R 17 45
PRAVASTATIN SODIUM 147 119 18 18
DONEPEZIL HCL 143 136 19 34
OXYCODONE HCL-ACETAMINOPHEN 142 45 S2 20 54
TAMSULOSIN HCL 129 117 21 25
PANTOPRAZOLE SODIUM 123 101 22 56
SERTRALINE HCL 123 91 22 28
POTASSIUM CHLORIDE 122 77 24 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 100 25 24
TRIAMCINOLONE ACETONIDE 110 75 26 94
TRAMADOL HCL 108 101 27 30
TRAZODONE HCL 106 30 28 47
ATORVASTATIN CALCIUM 106 85 28 19
RANITIDINE HCL 105 65 30 29
ALLOPURINOL 102 70 31 26
GLYBURIDE 101 93 R 32 46
OXYCODONE HCL 98 34 S2 33 36
CLOPIDOGREL 97 83 34 33
AZITHROMYCIN 96 56 35 35
FLUOXETINE HCL 96 43 35 37
AMITRIPTYLINE HCL 89 36 R 37 72
CITALOPRAM HBR 86 51 38 23
GLIPIZIDE 84 75 39 32
CLONIDINE HCL 83 73 40 50
CARVEDILOL 83 82 40 21
FLUTICASONE PROPIONATE 80 45 42 27
METOPROLOL SUCCINATE 79 68 43 22
FINASTERIDE 76 72 44 60
DIGOXIN 76 67 44 66
NAPROXEN 75 59 46 85
RISPERIDONE 73 67 47 75
NAMENDA 73 73 47 59
LEVOFLOXACIN 73 57 47 95
TRICOR 72 48 50 128
PLAVIX 72 59 50 51
HYDRALAZINE HCL 71 53 52 64
GEMFIBROZIL 71 32 52 62
ZETIA 67 63 54 103
ALENDRONATE SODIUM 66 59 55 16
LOSARTAN-HYDROCHLOROTHIAZIDE 65 49 56 31
MORPHINE SULFATE ER 65 0 S2 56 48
LANTUS SOLOSTAR 63 52 58 74
NEXIUM 58 47 59 84
IBUPROFEN 58 37 59 55
GLIMEPIRIDE 58 53 59 39
DETROL LA 58 52 59 280
PEN NEEDLE 57 39 63 81
DIOVAN 56 48 64 69
PROAIR HFA 56 38 64 68
ALPRAZOLAM 54 25 66 186
ADVAIR DISKUS 54 26 66 53
LANTUS 53 34 68 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.